ACERUS OTC Stock Analysis

ASPCF -  USA Stock  

USD 0.0359  0.00  0.00%

The latest price surge of ACERUS PHARMACEUTICALS could raise concerns from shareholders as the entity it trading at a share price of 0.0359 on very low momentum in volume. The company management teams may have good odds in positioning the entity resources to exploit market volatility in October. The stock standard deviation of daily returns for 90 days investing horizon is currently 11.62. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the ACERUS PHARMACEUTICALS partners.
Please continue to Trending Equities.

Search O TC Stock Analysis 

 
Refresh
The ACERUS PHARMACEUTICALS otc stock analysis report makes it easy to digest most publicly released information about ACERUS PHARMACEUTICALS and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. ACERUS OTC Stock analysis module also helps to analyze the ACERUS PHARMACEUTICALS price relationship with some important fundamental indicators such as market cap and management efficiency.

ACERUS OTC Stock Analysis Notes

About 91.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.03. ACERUS PHARMACEUTICALS had not issued any dividends in recent years. Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for mens and womens health. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada. ACERUS PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 10 people.The quote for ACERUS PHARMACEUTICALS CORP is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on ACERUS PHARMACEUTICALS CORP please contact Edward Gudaitis at 416 679 0771 or go to http://www.aceruspharma.com.

ACERUS PHARMACEUTICALS Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. ACERUS PHARMACEUTICALS's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding ACERUS PHARMACEUTICALS CORP or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
ACERUS PHARMACEUTICALS is not yet fully synchronised with the market data
ACERUS PHARMACEUTICALS is way too risky over 90 days horizon
ACERUS PHARMACEUTICALS has some characteristics of a very speculative penny stock
ACERUS PHARMACEUTICALS appears to be risky and price may revert if volatility continues
ACERUS PHARMACEUTICALS has high likelihood to experience some financial distress in the next 2 years
The company has accumulated 13.16 M in total debt with debt to equity ratio (D/E) of 2.61, implying the company greatly relies on financing operations through barrowing. ACERUS PHARMACEUTICALS has a current ratio of 0.66, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
The entity reported the revenue of 1.56 M. Net Loss for the year was (34.05 M) with loss before overhead, payroll, taxes, and interest of (929 K).
ACERUS PHARMACEUTICALS CORP has accumulated about 2.6 M in cash with (23.57 M) of positive cash flow from operations.
Roughly 91.0% of ACERUS PHARMACEUTICALS shares are held by company insiders

ACERUS Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 45.67 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ACERUS PHARMACEUTICALS's market, we take the total number of its shares issued and multiply it by ACERUS PHARMACEUTICALS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Management Efficiency

The entity has return on total asset (ROA) of (103.13) % which means that it has lost $103.13 on every $100 spent on asset. This is way below average. ACERUS PHARMACEUTICALS management efficiency ratios could be used to measure how well acerus pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

ACERUS PHARMACEUTICALS Technical and Predictive Indicators

About ACERUS OTC Stock Analysis

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how ACERUS PHARMACEUTICALS stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling ACERUS shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as ACERUS PHARMACEUTICALS. By using and applying ACERUS OTC Stock analysis, traders can create a robust methodology for identifying ACERUS entry and exit points for their positions.
Acerus Pharmaceuticals Corporation, a specialty pharmaceutical company, focuses on the development, manufacture, marketing, and distribution of pharmaceutical products for mens and womens health. Acerus Pharmaceuticals Corporation was founded in 2008 and is headquartered in Mississauga, Canada. ACERUS PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 10 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding ACERUS PHARMACEUTICALS to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module
Please continue to Trending Equities. Note that the ACERUS PHARMACEUTICALS information on this page should be used as a complementary analysis to other ACERUS PHARMACEUTICALS's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for ACERUS OTC Stock analysis

When running ACERUS PHARMACEUTICALS price analysis, check to measure ACERUS PHARMACEUTICALS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ACERUS PHARMACEUTICALS is operating at the current time. Most of ACERUS PHARMACEUTICALS's value examination focuses on studying past and present price action to predict the probability of ACERUS PHARMACEUTICALS's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move ACERUS PHARMACEUTICALS's price. Additionally, you may evaluate how the addition of ACERUS PHARMACEUTICALS to your portfolios can decrease your overall portfolio volatility.
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
The market value of ACERUS PHARMACEUTICALS is measured differently than its book value, which is the value of ACERUS that is recorded on the company's balance sheet. Investors also form their own opinion of ACERUS PHARMACEUTICALS's value that differs from its market value or its book value, called intrinsic value, which is ACERUS PHARMACEUTICALS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ACERUS PHARMACEUTICALS's market value can be influenced by many factors that don't directly affect ACERUS PHARMACEUTICALS underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ACERUS PHARMACEUTICALS's value and its price as these two are different measures arrived at by different means. Investors typically determine ACERUS PHARMACEUTICALS value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ACERUS PHARMACEUTICALS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.